TTM
4.4%
YoY change
−1.08pp
Trough year (1998)
0.0%
Peak year (2009)
13.6%
Latest annual
4.9%
EBITDA Margin history chart for Elevance Health (ELV) from 1998 to 2025
Latest: 4.9%
EBITDA Margin change chart for Elevance Health (ELV) from 1998 to 2025
Latest: −1.08pp
EBITDA Margin history table for Elevance Health (ELV) from 1998 to 2025
| 2025 | 4.9% | -1.08pp | ||
| 2024 | 5.9% | -0.19pp | ||
| 2023 | 6.1% | -0.34pp | ||
| 2022 | 6.5% | -0.76pp | ||
| 2021 | 7.2% | +0.52pp | ||
| 2020 | 6.7% | -0.84pp | ||
| 2019 | 7.5% | -0.00pp | ||
| 2018 | 7.5% | +1.34pp | ||
| 2017 | 6.2% | -1.07pp | ||
| 2016 | 7.3% | -0.53pp | ||
| 2015 | 7.8% | -0.06pp | ||
| 2014 | 7.9% | +0.35pp | ||
| 2013 | 7.5% | -0.78pp | ||
| 2012 | 8.3% | +0.04pp | ||
| 2011 | 8.3% | -0.87pp | ||
| 2010 | 9.1% | -4.50pp | ||
| 2009 | 13.6% | +6.94pp | ||
| 2008 | 6.7% | -3.53pp | ||
| 2007 | 10.2% | -0.14pp | ||
| 2006 | 10.4% | +1.25pp | ||
| 2005 | 9.1% | +0.21pp | ||
| 2004 | 8.9% | -0.61pp | ||
| 2003 | 9.5% | +7.60pp | ||
| 2002 | 1.9% | -3.97pp | ||
| 2001 | 5.9% | +5.90pp | ||
| 2000 | 0.0% | 0.00pp | ||
| 1999 | 0.0% | 0.00pp | ||
| 1998 | 0.0% | — |
- 20254.9%-1.08pp
- 20245.9%-0.19pp
- 20236.1%-0.34pp
- 20226.5%-0.76pp
- 20217.2%+0.52pp
- 20206.7%-0.84pp
- 20197.5%-0.00pp
- 20187.5%+1.34pp
- 20176.2%-1.07pp
- 20167.3%-0.53pp
- 20157.8%-0.06pp
- 20147.9%+0.35pp
- 20137.5%-0.78pp
- 20128.3%+0.04pp
- 20118.3%-0.87pp
- 20109.1%-4.50pp
- 200913.6%+6.94pp
- 20086.7%-3.53pp
- 200710.2%-0.14pp
- 200610.4%+1.25pp
- 20059.1%+0.21pp
- 20048.9%-0.61pp
- 20039.5%+7.60pp
- 20021.9%-3.97pp
- 20015.9%+5.90pp
- 20000.0%0.00pp
- 19990.0%0.00pp
- 19980.0%—
EBITDA Margin values are taken from Elevance Health's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA Margin at Elevance Health (ELV)
According to Elevance Health's latest reported financial statements, the company's latest reported EBITDA margin is 4.4%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual EBITDA margin for Elevance Health (ELV) came in at 4.85% – contracted 1.1 percentage points year-over-year.
The record annual EBITDA margin stands at 13.63%, reached in 2009; the historical low of 0.00% was recorded in 1998.
Elevance Health EBITDA Margin by Year
Elevance Health EBITDA Margin 2025: 4.9%
Elevance Health posted EBITDA margin of 4.85% in 2025, contracted 1.1 percentage points from 2024.
Elevance Health EBITDA Margin 2024: 5.9%
In 2024, Elevance Health reported EBITDA margin of 5.93%, contracted 0.2 percentage points from 2023.
Elevance Health EBITDA Margin 2023: 6.1%
Elevance Health EBITDA margin in 2023 was 6.12%, contracted 0.3 percentage points from 2022.
Elevance Health EBITDA Margin 2022: 6.5%
2022's EBITDA margin for Elevance Health came in at 6.47%, contracted 0.8 percentage points from 2021.
Elevance Health EBITDA Margin 2021: 7.2%
Elevance Health EBITDA margin in 2021 was 7.23%.
See more financial history for Elevance Health (ELV).
Sector peers by EBITDA Margin
Healthcare peers of Elevance Health (ELV), ranked by their latest EBITDA margin
| 55.4% | |
| 46.6% | |
| 45.9% | |
| 34.6% | |
| 33.9% | |
| 30.3% | |
| 26.9% | |
| 5.1% |
- 55.4%
- 46.6%
- 45.9%
- 34.6%
- 33.9%
- 26.9%
Frequently asked questions
Elevance Health (ELV) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation